← Peptide Library
Research GradeAppearance & Skin Health
PT-141 (Bremelanotide)
10 mg
MC4R-selective melanocortin agonist.
Overview
PT-141 (Bremelanotide) is a metabolite of Melanotan II developed as a MC4R-preferential agonist for neuroendocrine pathway research.
Mechanism of Action
Activates hypothalamic MC4R, influencing dopaminergic outflow in regions associated with arousal-response circuits.
Research Findings
Bremelanotide Mechanism
J. Sex. Med., 2019
MC4R-mediated central pathways.
Potential Research Applications
- Neuroendocrine research
- MC4R selective pharmacology